These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28602055)

  • 1. Evaluation of the Benefit of Radiotherapy in Patients with Occult Breast Cancer: A Population-Based Analysis of the SEER Database.
    Kim BH; Kwon J; Kim K
    Cancer Res Treat; 2018 Apr; 50(2):551-561. PubMed ID: 28602055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Influencing Management and Outcome in Patients with Occult Breast Cancer with Axillary Lymph Node Involvement: Analysis of the National Cancer Database.
    Hessler LK; Molitoris JK; Rosenblatt PY; Bellavance EC; Nichols EM; Tkaczuk KHR; Feigenberg SJ; Bentzen SM; Kesmodel SB
    Ann Surg Oncol; 2017 Oct; 24(10):2907-2914. PubMed ID: 28766198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axillary lymph node dissection plus radiotherapy may be an optimal strategy for patients with occult breast cancer.
    Li L; Zhang D; Wen T; Wu Y; Lv D; Zhai J; Ma F
    J Natl Cancer Cent; 2022 Dec; 2(4):198-204. PubMed ID: 39036544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: a nationwide retrospective study.
    Sohn G; Son BH; Lee SJ; Kang EY; Jung SH; Cho SH; Baek S; Lee YR; Kim HJ; Ko BS; Yu ; Lee JW; Ahn SH
    J Surg Oncol; 2014 Sep; 110(3):270-4. PubMed ID: 24863883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparable Survival between Additional Radiotherapy and Local Surgery in Occult Breast Cancer after Axillary Lymph Node Dissection: A Population-based Analysis.
    Wu SG; Zhang WW; Sun JY; Li FY; Lin HX; Chen YX; He ZY
    J Cancer; 2017; 8(18):3849-3855. PubMed ID: 29151972
    [No Abstract]   [Full Text] [Related]  

  • 6. Reconceptualizing the clinicopathological features, locoregional therapy and prognostic factors of occult breast cancer in the era of molecular subtyping.
    Ye X; Yang L; He Q; Lin X; Wang J; Cui R; Xu C
    Women Health; 2023 Feb; 63(2):105-114. PubMed ID: 36576239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological characteristics and treatment outcomes of occult breast cancer: a SEER population-based study.
    Ge LP; Liu XY; Xiao Y; Gou ZC; Zhao S; Jiang YZ; Di GH
    Cancer Manag Res; 2018; 10():4381-4391. PubMed ID: 30349371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy for malignant phyllodes tumor of the breast: An analysis of SEER data.
    Kim YJ; Kim K
    Breast; 2017 Apr; 32():26-32. PubMed ID: 28013032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
    Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
    Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcomes and unfavorable prognostic factors in patients with occult breast cancer.
    He M; Tang LC; Yu KD; Cao AY; Shen ZZ; Shao ZM; Di GH
    Eur J Surg Oncol; 2012 Nov; 38(11):1022-8. PubMed ID: 22959166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes.
    Bonneau C; Hequet D; Estevez JP; Pouget N; Rouzier R
    Eur J Surg Oncol; 2015 Aug; 41(8):998-1004. PubMed ID: 25986854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study of optimal surgical management for occult breast carcinoma: Mastectomy or quadrantectomy?
    Huang Y; Wu H; Luo Z
    Medicine (Baltimore); 2017 Dec; 96(52):e9490. PubMed ID: 29384945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of radiotherapy in metaplastic breast cancer: a propensity score-matched analysis of the SEER database.
    Li Y; Chen M; Pardini B; Dragomir MP; Lucci A; Calin GA
    J Transl Med; 2019 Sep; 17(1):318. PubMed ID: 31547814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.
    Chen QX; Wang XX; Lin PY; Zhang J; Li JJ; Song CG; Shao ZM
    Oncotarget; 2017 Jan; 8(3):4773-4780. PubMed ID: 27999201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Lymph Node Ratio and Disease Specific Survival in Breast Cancer Patients with One or Two Positive Lymph Nodes Stratified by Different Local Treatment Modalities.
    Hong R; Dai Z; Zhu W; Xu B
    PLoS One; 2015; 10(10):e0138908. PubMed ID: 26513258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the number of positive lymph nodes in women with T1-2N1 breast cancer treated with mastectomy: should patients with 1, 2, and 3 positive lymph nodes be grouped together?
    Dai Kubicky C; Mongoue-Tchokote S
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1200-5. PubMed ID: 23265570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer?
    Fu Y; Chung D; Cao MA; Apple S; Chang H
    Ann Surg Oncol; 2014 Dec; 21(13):4109-23. PubMed ID: 25081336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diminished survival in patients with inner versus outer quadrant breast cancers.
    Gaffney DK; Tsodikov A; Wiggins CL
    J Clin Oncol; 2003 Feb; 21(3):467-72. PubMed ID: 12560437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological characteristics and treatment outcomes of occult breast cancer: a population-based study.
    Zhao Z; Zhang T; Yao Y; Lu X
    BMC Surg; 2022 Apr; 22(1):143. PubMed ID: 35430796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant radiation therapy and survival for adenoid cystic carcinoma of the breast.
    Sun JY; Wu SG; Chen SY; Li FY; Lin HX; Chen YX; He ZY
    Breast; 2017 Feb; 31():214-218. PubMed ID: 27915203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.